These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 35515121)
1. FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies. Shen W; Zhou Q; Peng C; Li J; Yuan Q; Zhu H; Zhao M; Jiang X; Liu W; Ren C Front Oncol; 2022; 12():880077. PubMed ID: 35515121 [TBL] [Abstract][Full Text] [Related]
2. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues. Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486 [TBL] [Abstract][Full Text] [Related]
3. FBXW7: a critical tumor suppressor of human cancers. Yeh CH; Bellon M; Nicot C Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763 [TBL] [Abstract][Full Text] [Related]
4. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells. Guo Z; Zhou Y; Evers BM; Wang Q Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of FBXW7 loss of function in human cancers. Fan J; Bellon M; Ju M; Zhao L; Wei M; Fu L; Nicot C Mol Cancer; 2022 Mar; 21(1):87. PubMed ID: 35346215 [TBL] [Abstract][Full Text] [Related]
6. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897 [TBL] [Abstract][Full Text] [Related]
7. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001 [TBL] [Abstract][Full Text] [Related]
8. FBXW7 in Cancer: What Has Been Unraveled Thus Far? Sailo BL; Banik K; Girisa S; Bordoloi D; Fan L; Halim CE; Wang H; Kumar AP; Zheng D; Mao X; Sethi G; Kunnumakkara AB Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30791487 [No Abstract] [Full Text] [Related]
9. Recent insight into the role of FBXW7 as a tumor suppressor. Yumimoto K; Nakayama KI Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998 [TBL] [Abstract][Full Text] [Related]
10. The Fbxw7/hCdc4 tumor suppressor in human cancer. Tan Y; Sangfelt O; Spruck C Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364 [TBL] [Abstract][Full Text] [Related]
11. [Research progress in the role of FBXW7 in drug resistance against non-small cell lung cancer]. Peng Z; Chen Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):444-448. PubMed ID: 31113922 [TBL] [Abstract][Full Text] [Related]
12. mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation. Koo J; Yue P; Deng X; Khuri FR; Sun SY Mol Cell Biol; 2015 Jul; 35(13):2344-55. PubMed ID: 25918246 [TBL] [Abstract][Full Text] [Related]
13. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch. Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065 [TBL] [Abstract][Full Text] [Related]
14. CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma. Zhang E; Chen S; Tang H; Fei C; Yuan Z; Mu X; Qin Y; Liu H; Fan Y; Tan M; Wang X Cancer Sci; 2022 Jan; 113(1):91-108. PubMed ID: 34741373 [TBL] [Abstract][Full Text] [Related]
16. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis. Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063 [TBL] [Abstract][Full Text] [Related]
17. Regulation mechanism of Fbxw7-related signaling pathways (Review). Zhou Z; He C; Wang J Oncol Rep; 2015 Nov; 34(5):2215-24. PubMed ID: 26324296 [TBL] [Abstract][Full Text] [Related]
18. Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair. Lan H; Sun Y Front Cell Dev Biol; 2021; 9():751574. PubMed ID: 34760892 [TBL] [Abstract][Full Text] [Related]
19. E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc. Zhong L; Zhang Y; Li M; Song Y; Liu D; Yang X; Yang D; Qu H; Lai L; Wang Q; Chen Z Aging (Albany NY); 2020 Dec; 12(23):24394-24423. PubMed ID: 33260160 [TBL] [Abstract][Full Text] [Related]
20. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]